Overview

Comparison of Time to Extubation Using Sugammadex or Neostigmine

Status:
Not yet recruiting
Trial end date:
2022-12-30
Target enrollment:
Participant gender:
Summary
A prospective blinded randomized clinical trial to compare time to extubation using Sugammadex versus Neostigmine/glycopyrrolate as reversal agents after use of neuromuscular blockade agents in an outpatient bronchoscopy suite.
Phase:
Phase 4
Details
Lead Sponsor:
Temple University
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Glycopyrrolate
Neostigmine